A REAL-WORLD DATABASE ANALYSIS OF HEMODIALYSIS PATIENTS PRESCRIBED A CHANGE IN PHOSPHATE BINDER THERAPY FROM CALCIUM ACETATE TO SUCROFERRIC OXYHYDROXIDE

被引：0
|
作者：
Rastogi, Anjay [1 ]
Parameswaran, Vidhya [2 ]
Ficociello, Linda [2 ]
Mullon, Claudy [2 ]
Kossmann, Robert [3 ]
机构：
[1] Univ Calif Los Angeles, Los Angeles, CA USA
[2] Fresenius Med Care Renal Therapies Grp, Waltham, MA USA
[3] Fresenius Med Care North Amer, Waltham, MA USA
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2020年 / 75卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
300
引用
收藏
页码：623 / 623
页数：1
相关论文
共 50 条
  • [31] Changes in serum albumin and other nutritional markers when using sucroferric oxyhydroxide as phosphate binder among hemodialysis patients: a historical cohort study
    Kamyar Kalantar-Zadeh
    Linda H. Ficociello
    Vidhya Parameswaran
    Nicolaos V. Athienites
    Claudy Mullon
    Robert J. Kossmann
    Daniel W. Coyne
    BMC Nephrology, 20
  • [32] Changes in serum albumin and other nutritional markers when using sucroferric oxyhydroxide as phosphate binder among hemodialysis patients: a historical cohort study
    Kalantar-Zadeh, Kamyar
    Ficociello, Linda H.
    Parameswaran, Vidhya
    Athienites, Nicolaos V.
    Mullon, Claudy
    Kossmann, Robert J.
    Coyne, Daniel W.
    BMC NEPHROLOGY, 2019, 20 (01)
  • [33] PHOSPHATE-BINDER THERAPY WITH SUCROFERRIC OXYHYDROXIDE REDUCES ENDOGENOUS CALCIPROTEIN PARTICLE FORMATION AND CRYSTALLIZATION IN A POSTHOC ANALYSIS OF A RANDOMIZED CONTROLLED TRIAL IN DIALYSIS PATIENTS
    Thiem, Ursula
    Hewitson, Tim D.
    Toussaint, Nigel D.
    Haller, Maria C.
    Pasch, Andreas
    Cejka, Daniel
    Smith, Edward
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
  • [34] SAFETY OF INTRAVENOUS PARICALCITOL TREATMENT IN CHINESE HEMODIALYSIS PATIENTS: A REAL-WORLD DATABASE ANALYSIS
    Wang, Niansong
    Jiang, Gengru
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
  • [35] Real-World Scenario Improvements in Serum Phosphorus Levels and Pill Burden in Peritoneal Dialysis Patients Treated with Sucroferric Oxyhydroxide
    Kalantar-Zadeh, Kamyar
    Parameswaran, Vidhya
    Ficociello, Linda H.
    Anderson, Ludmila
    Ofsthun, Norma J.
    Kwoh, Christopher
    Mullon, Claudy
    Kossmann, Robert J.
    Coyne, Daniel W.
    AMERICAN JOURNAL OF NEPHROLOGY, 2018, 47 (03) : 153 - 161
  • [36] A comparison of the calcium-free phosphate binder sevelamer hydrochloride with calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients
    Bleyer, AJ
    Burke, SK
    Dillon, M
    Garrett, B
    Kant, KS
    Lynch, D
    Rahman, SN
    Schoenfeld, P
    Teitelbaum, I
    Zeig, S
    Slatopolsky, E
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 33 (04) : 694 - 701
  • [37] Efficacy and safety of intravenous paricalcitol treatment in Chinese hemodialysis patients: a real-world database analysis
    Wang, Niansong
    Xie, Yuting
    Jiang, Gengru
    ANNALS OF PALLIATIVE MEDICINE, 2022, 11 (01) : 225 - 239
  • [38] SERUM PHOSPHORUS MANAGEMENT IN HEMODIALYSIS (HD) PATIENTS WHO INITIATED SUCROFERRIC OXYHYDROXIDE (SO) AS A FIRST-LINE PHOSPHATE BINDER WITHIN THE FIRST YEAR OF HD
    Medaura, Juan
    Zhou, Meijiao
    Ficociello, Linda
    Anger, Michael
    Sprague, Stuart
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2023, 81 (04) : S56 - S56
  • [39] One-Year Follow-Up of Maintenance Hemodialysis (HD) Patients Who Switched Phosphate Binder (PB) Prescription from Ferric Citrate (FC) to Sucroferric Oxyhydroxide (SO)
    Ficociello, Linda
    Zhou, Meijiao
    Parameswaran, Vidhya
    Mullon, Claudy
    Anger, Michael S.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 207 - 207
  • [40] PHOSPHATE BINDER (PB) PILL BURDEN AND ACHIEVEMENT OF WITHIN-RANGE SERUM PHOSPHORUS (sP) AMONG HISPANIC HEMODIALYSIS (HD) PATIENTS TREATED WITH SUCROFERRIC OXYHYDROXIDE (SO)
    Henriquez, Mario
    Fiociello, Linda H.
    Parameswaran, Vidhya
    Mullon, Claudy
    Kossmann, Robert J.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2017, 69 (04) : A51 - A51
12345